Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.
about
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsDecitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy aloneDecreased expression of EZH2 reactivates RASSF2A by reversal of promoter methylation in breast cancer cells.Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study.Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy.
P2860
Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Epigenetic priming with decita ...... n high-risk myeloid neoplasms.
@en
Epigenetic priming with decita ...... n high-risk myeloid neoplasms.
@nl
type
label
Epigenetic priming with decita ...... n high-risk myeloid neoplasms.
@en
Epigenetic priming with decita ...... n high-risk myeloid neoplasms.
@nl
prefLabel
Epigenetic priming with decita ...... n high-risk myeloid neoplasms.
@en
Epigenetic priming with decita ...... n high-risk myeloid neoplasms.
@nl
P2093
P2860
P1433
P1476
Epigenetic priming with decita ...... n high-risk myeloid neoplasms.
@en
P2093
Gai-Xiang Xu
Hong-Yan Tong
Jian Huang
Jing-Han Wang
Ju-Ying Wei
P2860
P304
P356
10.3109/10428194.2015.1091931
P50
P577
2015-10-13T00:00:00Z